James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 9,000 shares at $1.73 ($16K) on 2019-06-25, disclosed to the SEC on 2019-06-26.
Open-market purchase of $16k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.73 | 200 | $346 | 2.2% |
| 2 | $1.73 | 1,400 | $2K | 15.6% |
| 3 | $1.73 | 7,400 | $13K | 82.2% |
| Total | $1.73 avg | 9,000 | $16K | 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |